Our study focuses on conducting a thorough benchmarking analysis of the AICP to evaluate its performance and capabilities. Specifically, we aim to highlight its ability to identify 2000 viable synthesis routes within approximately 40 minutes, showcasing its potential for high-throughput synthesis in drug discovery. By addressing scalability we strive to accelerate the process of identifying and developing novel drug candidates with the potential to address unmet medical needs.